Jeffrey Berkowitz

Jeffrey Berkowitz is a Venture Advisor at Israel Biotech Fund. Jeffrey is also the CEO at Real Endpoints. Jeff is one of the rare executives whose career has spanned most key verticals in global healthcare with the executive committee and other senior roles at UnitedHealth Group, Walgreens Boots Alliance, and Merck.

Prior to Real Endpoints, Jeff served as an Executive Vice President of UnitedHealth Group/Optum where he leads Optum’s International division as CEO while also driving key strategic initiatives within Optum’s pharmacy benefits management division.

Prior to joining UnitedHealth Group/Optum in 2016, Jeff served at the Walgreens Boots Alliance, Inc. as President of Pharma and Global Market Access. Berkowitz serves on the board of directors of Lundbeck, Esperion Therapeutics, and Infinity Pharmaceuticals, Inc. He also serves on the boards of the privately held ZappRx and Braeburn.

Berkowitz also serves on the board of the non-profit, Project Explorer and served on the Board of Directors of the Swiss-American Chamber of Commerce.